Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation

Sheerin, N; Harrison, N K; Sheppard, M N; Hansell, D M; Yacoub, M; Clark, T J
February 1995
Thorax;Feb1995, Vol. 50 Issue 2, p207
Academic Journal
No abstract available.


Related Articles

  • EMT, OB and lung transplantation.  // Thorax;Sep2009, Vol. 64 Issue 9, p31 

    The article discusses the influence of epithelial mesenchymal transition (EMT) to the development of obliterative bronchiolitis (OB). It indicates that the success of lung transplantation is limited due to the development of OB. An explanation about the process of EMT and the pathological basis...

  • The possible involvement of human herpesvirus type 6 in obliterative bronchiolitis after bone marrow transplantation. Nishimaki, K.; Okada, S.; Miyamura, K.; Ohno, I.; Ashino, Y.; Sugawara, T.; Kondo, T.; Hattori, T. // Bone Marrow Transplantation;Dec2003, Vol. 32 Issue 11, p1103 

    Examines the possible involvement of human herpesvirus type 6 (HHV-6) in obliterative bronchiolitis after bone marrow transplantation. Background on obliterative bronchiolitis; Clinical history of a patient who developed obliterative bronchiolitis after receiving bone marrow transplantation;...

  • Challenges in pulmonary fibrosis · 2 : Bronchiolocentric fibrosis. Cordier, Jean-François // Thorax;Jul2007, Vol. 62 Issue 7, p638 

    Bronchiolocentric fibrosis is essentially represented by the pathological pattern of constrictive fibrosis bronchiolitis obliterans. The corresponding clinical condition (obliterative bronchiolitis) is characterised by dyspnoea, airflow obstruction at lung function testing and air trapping with...

  • Developments in Inhaled Immunosuppressive Therapy for the Prevention of Pulmonary Graft Rejection. Akamine, S.; Katayama, Y.; Higenbottam, T.; Lock, T. // BioDrugs;1998, Vol. 9 Issue 1, p49 

    Cyclosporin is the main immunosuppressive treatment for lung and heart-lung transplantation. When combined with azathioprine and oral corticosteroids, repeated episodes of acute rejection are limited to a minority of transplant patients. Despite early successful transplantation, many patients...

  • Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation. Parissis, Haralabos; Gould, Kate; Dark, John // Journal of Cardiothoracic Surgery;2010, Vol. 5, p70 

    Background: To report our experience of a rather uncommon drug interaction, resulting in hemolytic uremic syndrome (HUS). Methods: Two consecutive cases of hemolytic uremic syndrome were diagnosed in our service. In both patients the use of macrolides in patients taking Tacrolimus, resulted in...

  • Lungentransplantation. Sommerwerck, U.; Rabis, T.; Fleimisch, P.; Carstens, H.; Teschler, H.; Kamler, M. // Herz;Feb2014, Vol. 39 Issue 1, p74 

    Lung transplantation is a therapeutic option for patients with end-stage lung diseases. Selection of candidates requires careful consideration of the disease-specific indications and contraindications for transplantation. Advances have been made in candidate selection via the ability to...

  • Biologies in the Treatment of Transplant Rejection and Ischemia/Reperfusion Injury. Pascher, Andreas; Klupp, Jochen // BioDrugs;2005, Vol. 19 Issue 4, p211 

    Tumor necrosis factor (TNF)-α inhibitors have proven efficacy in various autoimmune diseases such as Crohn disease, rheumatoid arthritis, psoriasis, and ankylosing spondylitis. Indeed, some TNFα inhibitors have already been approved for the management of the inflammatory manifestations...

  • Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link? Wilkes, David S. // Journal of Clinical Investigation;Jun2011, Vol. 121 Issue 6, p2155 

    Chronic lung allograft rejection, known as obliterative bronchiolitis (OB), is the leading cause of death in lung transplant patients. Although OB pathogenesis is not fully understood, in this issue of the JCI, Jiang and colleagues report that tissue hypoxia resulting in dysfunctional airway...

  • Percutaneous Stenting to Treat Pulmonary Vein Stenosis. Loyalka, Pranav; Cevik, Cihan; Nathan, Sriram; Gregoric, Igor D.; Kar, Biswajit; Parulekar, Amit; Scheinin, Scott A.; Seethamraju, Harish // Texas Heart Institute Journal;2012, Vol. 39 Issue 4, p560 

    Pulmonary vein stenosis after lung transplantation is rare. Untreated, it can cause transplant failure and death. We describe the case of a 56-year-old man in whom pulmonary vein stenosis developed after single-lung transplantation. He was successfully treated with angioplasty and stent...

  • Successful retransplantation of the heart and lungs in an adult with cystic fibrosis. Madden, B. P.; Khaghani, A.; Yacoub, M. // Journal of the Royal Society of Medicine;Sep1991, Vol. 84 Issue 9, p561 

    The article presents a case study of a patient who suffered from cystic fibrosis and had bronchiolitis and lymphoproliferative disorders. A woman aged 33 years had no respiratory symptoms. In her late teens she suffered from repeated pneomothoraces bilaterally which required tetracycline...


Read the Article


Sign out of this library

Other Topics